Increased risk of stroke among patients with ulcerative colitis: a population-based matched cohort study

Joseph J Keller1, Jui Wang, Ya-Li Huang

  • 1School of Public Health, College of Public Health and Nutrition, Taipei Medical University, Taipei, Taiwan.

Insights

Patients with ulcerative colitis (UC) face a doubled risk of subsequent stroke, particularly those over 50. This finding highlights the importance of stroke risk assessment in UC patients.

Area of Science:

  • Gastroenterology
  • Neurology
  • Epidemiology

Background:

  • Inflammatory bowel disease (IBD), including ulcerative colitis (UC), is linked to increased risks of venous thromboembolism and atherosclerosis.
  • The association between UC and stroke risk remains controversial in existing literature.

Purpose of the Study:

  • To investigate the risk of subsequent stroke in patients diagnosed with ulcerative colitis (UC).
  • To compare stroke risk in UC patients versus a matched cohort without IBD using population-based data.

Main Methods:

  • Analysis of administrative claims data from Taiwan's National Health Insurance Database.
  • Inclusion of 516 UC patients and 2,579 IBD-free comparison subjects.
  • Utilized Cox proportional hazards regressions to assess stroke risk, with subgroup analyses by age and gender.

Main Results:

  • Adjusted analyses revealed a 2.045-fold increased hazard ratio (HR) for subsequent stroke in UC patients compared to controls.
  • Increased stroke risk was significant for UC patients over 50 years old.
  • The association remained significant in both men (HR=2.153) and women (HR=2.750).

Conclusions:

  • This cohort study identified a significantly elevated risk of subsequent stroke among Taiwanese UC patients.
  • The findings underscore the need for vigilance regarding cerebrovascular events in the UC population.
Abstract

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
34
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
705
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
33
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
3.0K
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
44